EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective Role of Linagliptin in Cisplatin‐Mediated Liver Injury: Involvement of STAT3 and AMPK/SIRT1/PGC‐1alpha Mitochondrial Energy Sensing Networks

Marawan A Elbaset iD, Bassim M S A Mohamed, Passant E Moustafa, Yosra Assem Hussien, Zeinab A El-Gendy, Sherif M Afifi, Tuba Esatbeyoglu iD, Alyaa Farouk Hessin, Reda Korany M S, Hany M Fayed iD

Advances in Pharmacological and Pharmaceutical Sciences · 2026-01 · 2026 (1)

DOI: 10.1155/adpp/6457551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Pharmacological and Pharmaceutical Sciences, online erschienen am 07.07.2026. Verfasst von Marawan A Elbaset und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt, nrc.sci.eg. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gottfried Wilhelm Leibniz Universität Hannover.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin (Cis), a commonly used chemotherapy drug, is associated with liver toxicity, which restricts its broader clinical use. This study investigated the potential protective effects of linagliptin (Lina), a DPP‐4 inhibitor, in preventing liver damage induced by Cis in rats. There were four groups of male rats: a control group, a Cis group (8 mg/kg, IP), and cotreated groups given Lina (5 and 10 mg/kg, orally) with Cis. Lina was administered daily for 15 days, with Cis injected on Day 8. Liver function, oxidative stress markers, inflammatory mediators, energy metabolism indicators, and key signaling proteins were assessed. Cis administration resulted in significant hepatotoxicity, evidenced by elevated liver enzymes, increased oxidative stress, enhanced inflammatory response, and disrupted energy metabolism. Lina treatment, particularly at the 10‐mg/kg dose, demonstrated marked hepatoprotective effects. It significantly reduced liver enzyme levels, improved antioxidant status, attenuated inflammatory markers, and restored energy metabolism indicators. Moreover, Lina positively modulated essential signaling proteins involved in cellular stress response and metabolism, including signal transducer and activator of transcription 3 (STAT3), transforming growth factor beta 1 (TGF‐β), silent information regulator 1 (SIRT1), and peroxisome proliferator–activated receptor gamma coactivator 1‐alpha (PGC‐1α). The results indicate that Lina protects against Cis‐induced liver damage by leveraging its antioxidant, anti‐inflammatory, and metabolic regulation properties. This study offers new insights into potential strategies for mitigating Cis‐induced hepatotoxicity and enhancing its therapeutic index in cancer treatment.

Schlagwörter

Stichwörter der Autor:innen

SIRT1 signalingcisplatinhepatoprotectionlinagliptinoxidative stress

Autor:innen und Institutionen

  • Department of Pharmacology, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt, nrc.sci.eg.
  • Department for Life Quality Studies, Rimini Campus, University of Bologna, Corso d'Augusto 237, Rimini, 47921, Italy, unibo.it.
  • Department of Molecular Food Chemistry and Food Development, Institute of Food and One Health, Gottfried Wilhelm Leibniz University Hannover, Am Kleinen Felde 30, Hannover, 30167, Germany, uni-hannover.de.
  • Department of Pathology, College of Veterinary Medicine, Cairo University, P.O. Box 12211, Cairo, Egypt, cu.edu.eg.

ORCID-Profile: Marawan A Elbaset, Tuba Esatbeyoglu, Hany M Fayed

Förderung

  • Gottfried Wilhelm Leibniz Universität Hannover

Zitieren

APA

Elbaset, M. A., Mohamed, B. M. S. A., Moustafa, P. E., Hussien, Y. A., El-Gendy, Z. A., Afifi, S. M., Esatbeyoglu, T., Hessin, A. F., M S, R. K., & Fayed, H. M. (2026). Protective Role of Linagliptin in Cisplatin‐Mediated Liver Injury: Involvement of STAT3 and AMPK/SIRT1/PGC‐1alpha Mitochondrial Energy Sensing Networks. Advances in Pharmacological and Pharmaceutical Sciences, 2026(1). https://doi.org/10.1155/adpp/6457551

Vancouver

Elbaset MA, Mohamed BMSA, Moustafa PE, Hussien YA, El-Gendy ZA, Afifi SM, et al. Protective Role of Linagliptin in Cisplatin‐Mediated Liver Injury: Involvement of STAT3 and AMPK/SIRT1/PGC‐1alpha Mitochondrial Energy Sensing Networks. Advances in Pharmacological and Pharmaceutical Sciences. 2026;2026(1). doi:10.1155/adpp/6457551

BibTeX
@article{Elbaset2026,
  author = {Elbaset, Marawan A and Mohamed, Bassim M S A and Moustafa, Passant E and Hussien, Yosra Assem and El-Gendy, Zeinab A and Afifi, Sherif M and Esatbeyoglu, Tuba and Hessin, Alyaa Farouk and M S, Reda Korany and Fayed, Hany M},
  title = {Protective Role of Linagliptin in Cisplatin‐Mediated Liver Injury: Involvement of STAT3 and AMPK/SIRT1/PGC‐1alpha Mitochondrial Energy Sensing Networks},
  journal = {Advances in Pharmacological and Pharmaceutical Sciences},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/adpp/6457551}
}
Kostenlos starten →